Email Updates

Search form

You are here

23 AUGUST 2019 VOLUME 20 ISSUE 32

Media Coverage

  • Deputy President David Mabuza on Friday convened an inaugural meeting of the National AIDS Council Inter-Ministerial Committee in the sixth administration to deliberate on South Africa's response to HIV and tuberculosis (TB) epidemics.

    August 23, 2019
    General
    Xinhua
  • The response to HIV/AIDS in several countries has been impeded by human resources for health shortages — and to make headway in the fight against HIV, many countries have received support from donors to hire thousands of additional health workers for HIV service delivery.

    August 22, 2019
    General
    Devex
  • The number of people testing for HIV across the country has been declining steadily over the past three years, according to Uganda AIDS Commission-UAC. Records from UAC show that 10.7 million people tested in the 2016/2017 financial year, 8.8 million in the 2017/2018 financial year and 7.2 million in the 2018/2019 financial year.

    August 22, 2019
    General
    Independent
  • Imagine HIV patients needed to take their antiretroviral therapies not every day, not even every month, but every two months. A GlaxoSmithKline two-drug injectable regimen that’s already under review by the FDA for monthly use could soon turn it into reality, thanks to a phase 3 win.

    August 22, 2019
    FiercePharma
  • The United States government says it has allocated an additional $75 million to the fight against HIV/AIDs in Nigeria through its President's Emergency Plan for AIDS Relief (PEPFAR). The US Ambassador to Nigeria, Stuart Symington, said this in a statement on Tuesday. He, however, stressed that disbursement of the additional PEPFAR HIV funds is contingent upon the Nigerian federal and state governments reducing or eliminating financial barriers to PLHIV access to services, in particular, fees charged by healthcare facilities for non-essential services or those already provided by PEPFAR.

    August 21, 2019
    General
    All Africa
  • Gilead Sciences took the unusual step of mounting a challenge to US government patents on Wednesday, saying the government’s claim to have invented the use of the drug Truvada for HIV prevention is invalid. The pharmaceutical company filed a petition with the US Patent and Trademark Office, asking for a reexamination of the government’s patents. Gilead says medical professionals were widely discussing Truvada, approved in 2004 for treating people already infected with HIV, for prevention of the disease before the government filed its patent claim in 2006.

    August 21, 2019
    Washington Post
  • The Federal Council on Wednesday approved a contribution of CHF64 million for the Global Fund to Fight AIDS, Tuberculosis and Malaria for the 2020–22 period and a further CHF30 million for the Joint United Nations Programme on HIV/AIDS for the 2019–21 period.

    August 21, 2019
    General
    Swissinfo.ch
  • Atlanta OKs Emergency Funding for AIDS/HIV Housing to Avert Crisis," said the Atlanta Journal Constitution. "There Aren't Enough Doctors to Treat HIV in the South" wrote the Pew Charitable Trusts. "North and South Carolina Team Up to Take on Interstate HIV Epidemic," reported the Aiken Standard. If you think these headlines were from 1989, you'd be wrong—they're from the past two years. While we've made tremendous progress in the fight against HIV, the epidemic is still very real for too many, particularly in the South.

    August 20, 2019
    General
    Newsweek
  • As HIV rates continue to climb in Canada, researchers are launching a clinical trial for an HIV self-testing kit that could be on sale in 2020.

    August 20, 2019
    General
    CBC
  • Voluntary HIV testing and counselling carried out in South African emergency departments (EDs) can reach at-risk populations with knowledge of their status and HIV treatment services, finds a new paper. They also found poor rates of HIV treatment and care retention among people living with HIV in these settings.

    August 20, 2019
    Avert
  • Last May, Gilead Sciences (GILD) chief executive Daniel O’Day testified before Congress that a revised version of a best-selling HIV pill was a “brand new medicine” and that the company was “absolutely not” aware it was safer than an older version during the early stages of development.

    August 19, 2019
    STAT News
  • Joseph Anthony, from Mgaza village in Morogoro narrates to Your Health how he got motivated to be circumcised after living with the foreskin for 21 years. Just like many other circumcised men, Joseph recalls that peer-influence triggered his decision to get circumcised.

    August 19, 2019
    The Citizen
  • Thousands of jobs are at stake as the US government reduces funding and reorients its HIV programme in Kenya. The US President’s Emergency Plan for AIDS Relief (PEPFAR) has drawn various redlines giving Kenya tough minimums to be met by October and next year or risk further funding cuts.

    August 18, 2019
    General
    Standard Digital
  • Researchers have described a "perfect storm" that has allowed the HIV virus to spread so quickly in Glasgow. Homelessness is the key factor. Combined with a significant rise in the numbers of people injecting cocaine as well as heroin.

    August 18, 2019
    General
    BBC
  • In the haste to get President Trump’s program off the ground, the input of community organizations who serve the Black community has been overlooked and ignored. But while there is a dire need for urgency, if the most impacted communities and individuals are not intentionally centered in the planning and execution of the plan, this opportunity will be squandered.

    August 16, 2019
    General
    OUT
  • Access to pre-exposure prophylaxis (PrEP) for young people at risk of HIV remains limited because of age-related consent laws and policies, reveals a global review.

    August 16, 2019
    Avert

Published Research

Announcements